ArticleBMC plant biology2025
Chitosan and copper nanoparticles in vase solutions elevate the quality and longevity of cut tulips, setting a new standard for sustainability in floriculture.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Extending calla lily vase life using silver nitrate, silver nanoparticles, and chlorogenic acid: a novel strategy to sustain xylem conductivity and antioxidant defense.BMC plant biology · 2026Article
- Synergistic effects of plant growth regulators, riboflavin, and iron nanoparticles on secondary metabolites in micropropagated Ceratonia siliqua L.Scientific reports · 2026Article
- The Senescence of Cut Daffodil Flowers Correlates with Programmed Cell Death Symptoms.International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanoparticles present innovative solutions for postharvest applications, allowing for the development of compounds that effectively extend the vase life of cut flowers by reducing ethylene production and preventing bacterial growth. As a leading choice among cut flowers, Tulips encounter common issues such as neck bending and a limited display life, which can severely impact their marketability. This experiment aims to evaluate the effectiveness of nano chitosan (CHS-NPs) at 3.5 and 7.0 mg L− 1, nano copper (Cu-NPs) at 15 and 30 mg L− 1, and Cymbopogon flexuosus essential oil (LG) at 150 and 300 mg L− 1 as innovative, eco-friendly solutions for improving the quality and extending the vase life of cut tulip flowers. The findings reveal that CHS-NPs and Cu-NPs significantly prolong the vase life of cut tulip flowers, with optimal concentrations determined to be 30 mg L− 1 Cu-NPs (15.56 and 16.33 days) and 7.5 mg L− 1 CHS-NPs (13.01 and 14.00 days), respectively. The greatest RFW% was 110.97 and 112.30% on day 7 in both seasons of cut tulip flowers treated with 30 mg L− 1Cu-NPs. These treatments enhance water uptake and relative fresh weight (RFW%), effectively inhibit microbial growth at the stem base, and prevent bacterial blockages in the xylem for up to seven days. Moreover, they substantially increase chlorophyll levels, total soluble carbohydrates, and proteins while decreasing hydrogen peroxide (H2O2) production, thereby enhancing membrane stability. At the same time, the highest SOD and CAT activity were 1.77 and 1.92 Units mg− 1 protein and 2.82 and 2.98 Units mg− 1 protein with the 30 mg L− 1 Cu-NPs in the first and second seasons, respectively. In conclusion, CHS-NPs at 7.5 mg L− 1 and Cu-NPs at 30 mg L− 1 significantly enhance the vase life of cut tulips by improving water balance and antioxidant activity, with Cu-NPs demonstrating better effectiveness. Adopting Cu-NPs at the recommended concentration should be prioritized in the tulip floral industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.